|
|
St. Jude Medical Riata Lead - Newsfeeds
-
-
a provider of heart valves and life-saving cardiac surgery products and Vice President of Global Marketing for the Cardiac Surgery Division of St Jude Medical, Inc. Mr. Reinhardt holds a Master of Business Administration in general business from Baruch ...
-
-
Johnson & Johnson rose $.54 or .9 percent, to $60.56. Medtronic rose $.33 or .8 percent, to $41.05. St Jude Medical rose $.76 or 1.5 percent, to $52.96. Stryker rose $.83 or 1.4 percent, to $60.70. Zimmer rose $1.83 or 3.0 percent, to $62.00.
-
-
Apr 15, 2011 (SmarTrend(R) News Watch via COMTEX) -- SmarTrend has detected shares of St Jude Medical ( STJ ) have bullishly opened above the pivot of $51.96 today and have reached the first resistance level of $52.60. We are watching for a cross of the ...
-
-
Apr 15, 2011 (SmarTrend(R) Market Surveillance via COMTEX) -- Today, shares of St Jude Medical ( STJ ) have crossed bullishly above their 10-day moving average of $52.51 on volume of 549 thousand shares. This may provide swing traders with an opportunity ...
-
-
Cameron International Corporation was founded in 1994 and is headquartered in Houston, Texas. ST JUDE MEDICAL INC (NYSE:STJ) - St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide.
-
-
St. Jude Medical, Inc. (NYSE: STJ ) has received U.S. FDA and European CE approval for its ShockGuard technology. From the release: "The technology, which can be used with new and existing Unify cardiac resynchronization therapy defibrillators (CRT-Ds) and ...
-
-
St. Jude Medical announced Thursday that U.S. and European regulators have approved its ShockGuard technology, which is designed to reduce inappropriate shocks in several of its defibrillator models. This is a new trend in med-tech: Last month, rival ...
-
-
ShockGuard Technology with new DecisionTx programming reduces inappropriate shocks while ensuring effective defibrillation when needed ST. PAUL, Minn.--( BUSINESS WIRE )--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced ...
-
-
Johnson & Johnson rose $.42 or .7 percent, to $60.02. Medtronic rose $.63 or 1.6 percent, to $40.72. St Jude Medical rose $.09 or .2 percent, to $52.20. Stryker rose $.03 or .1 percent, to $59.87. Zimmer rose $.30 or .5 percent, to $60.17.
-
-
Jefferies is reiterating its Buy rating on shares of St. Jude Medical (NYSE: STJ ) and is raising its price target from $49 to $59 following a survey conducted of 51 electrophysiologists to assess market trends and to gauge interest in new technologies ...
-
-
St. Jude Medical Inc. said Thursday federal regulators have approved its technology for reducing the number of shocks to people with implantable heart defibrillators. The approval from the Food and Drug Administration comes just a couple of weeks after ...
-
-
There are no prospective, controlled studies where patients have been randomized to permit driving or studies where patients have been randomized to receive or not to receive physician advice not to drive. Therefore, the Canadian Cardiovascular Society ...
-
-
He also brings exceptional communications skills in the area of healthcare. He served as Director of Marketing Communications for St. Jude Medical and was the Principal in The H is Silent, a medical marketing communications company. He continues to provide ...
-
-
7 percent, to $56.58. Johnson & Johnson fell $.34 or .6 percent, to $59.60. Medtronic fell $.18 or .4 percent, to $40.09. St Jude Medical fell $.01 or percent, to $52.11. Stryker rose $.15 or .3 percent, to $59.84. Zimmer rose $.21 or .4 percent ...
-
-
And for Minnesota, Medtronic (a $15 billion company) was launched. Manny Villafana was the first international sales administrator of Medtronic and went on to found St. Jude Medical (a $5 billion company) and five other successful medical device companies ...
-
-
Company Share (%),United States Neurology Devices Market, 2010 132 Figure 69: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2010 133 Figure 70: St. Jude Medical, Inc., Company Share (%),United States Neurology ...
-
-
Braun Melsungen AG, Company Share (%),China Neurology Devices Market, 2010 123 Figure 66: St. Jude Medical, Inc., Company Share (%),China Neurology Devices Market, 2010 124 Figure 67: DePuy, Inc., Company Share (%),China Neurology Devices Market ...
-
-
Also , the company has no material long-term debt obligations. St Jude Medical ( STJ ) is up by 6.8%, since the March 11 close. In 2010, revenues increased 10% to $5.16 B, and GAAP EPS grew by 21.7% to $2.75. The net margin is 17.6%, which higher than most ...
-
-
Cameron International Corporation was founded in 1994 and is headquartered in Houston, Texas. ST JUDE MEDICAL INC (NYSE:STJ) - St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide.
-
-
St Jude Medical ( NYSE:STJ ) traded in a range yesterday that spanned from a low of $51.96 to a high of $52.54. Yesterday's low of the day pierced the 3-day low of $52.11 on volume of 2 million shares. Shares of St Jude Medical have been range bound for ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
Pages:
Previous
1
2
3
4
5
6
7
8
9
10
11
...
Next
|
St. Jude Medical Riata Lead Information
|
